Karani Asset Management’s Eli Lilly LLY Stock Holding History

Karani Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Sell	1,028 -2	-0.2%	-$2.04K	0.89%	28
2026 Q1	$947K	Sell	1,030 -104	-9%	-$105K	0.78%	29
2025 Q4	$1.22M	Sell	1,134 -22	-2%	-$21K	1%	21
2025 Q3	$882K	Sell	1,156 -169	-13%	-$126K	0.7%	25
2025 Q2	$1.03M	Buy	1,325 +600	+83%	+$466K	1%	23
2025 Q1	$599K	Buy	+725	New	+$603K	0.63%	31

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Karani Asset Management's LLY Position: Q2 2026 in Review

Karani Asset Management reduced its Eli Lilly (LLY) stake by 0.19% in Q2 2026, selling an estimated $2.04K and leaving 1,028 shares worth $1.23M. The position accounts for 0.89% of the portfolio, ranked #28.

Karani Asset Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Karani Asset Management held 1,028 shares of Eli Lilly worth $1.23M as of Q2 2026.
Karani Asset Management sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
Eli Lilly made up 0.89% of Karani Asset Management's portfolio in Q2 2026, its #28 holding.
Karani Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Karani Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.